[TOVX] YoY Quarter Result on 30-Sep-2016 [#Q3]

Stock
[TOVX] Theriva Biologics, Inc.
Announcement Date
30-Sep-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- -47.01%
YoY- -23.31%
Quarter Report
TOVX's Result
TOVX's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -5,150 -3,689 -10,930 -8,489 -7,507 -4,910 -3,368 7.33%
Tax -30 -640 5,080 -803 -4,876 0 3 -
NP -5,120 -3,680 -10,922 -8,353 -6,774 -4,910 -3,368 7.22%
Tax Rate - - - - - - - -
Total Cost 5,120 3,680 10,922 8,353 6,774 4,910 3,368 7.22%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
EPS -3.05 -9.14 -29.80 -31.97 -27.58 -29.40 -26.40 -30.20%
EPS Diluted -3.05 -9.14 -29.80 -31.97 -27.07 -29.40 -26.40 -30.20%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.